🇺🇸 FDA
Patent

US 9458086

Compositions and methods for adipocyte modulation

granted A61KA61K31/05A61K31/137

Quick answer

US patent 9458086 (Compositions and methods for adipocyte modulation) held by The United States of America as Represented by the Department of Veterans Affairs Office of General Counsel—PSG IV (024) expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Department of Veterans Affairs Office of General Counsel—PSG IV (024)
Grant date
Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/05, A61K31/137, A61K45/06